Author:
Liu Chao,Yi Juan,Lu Ming,Yang Ping,Du Chunjing,Jiang Fan,Du Pengcheng,Shen Ning
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference31 articles.
1. Mechanisms and clinical relevance of bacterial heteroresistance;Andersson;Nat. Rev. Microbiol.,2019
2. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial;Bassetti;Lancet Infect. Dis.,2021
3. In vitro activity of the novel siderophore cephalosporin, cefiderocol, in gram-negative pathogens in Europe by site of infection;Candel;Clin. Microbiol. Infect.,2022
4. Widespread cefiderocol heteroresistance in carbapenem-resistant gram-negative pathogens;Choby;Lancet Infect. Dis.,2021
5. Increased bla(KPC) copy number and OmpK35 and OmpK36 porins disruption mediated resistance to imipenem/relebactam and meropenem/vaborbactam in a KPC-producing klebsiella pneumoniae clinical isolate;Gaibani;Antimicrob. Agents Chemother.,2022
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献